Forging Gene Therapy Capacity and a Pipeline at the Same Time

RARECast - Podcast autorstwa RARECast - Czwartki

Kategorie:

Tim Miller, co-founder and CEO of Forge Biologics, discusses the company’s hybrid business model, how it hopes to differentiate itself through its shared experience with its customers, and its emerging pipeline of gene therapies to treat rare diseases.

Visit the podcast's native language site